Genentech, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
C07K PEPTIDES 1157 1
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1103 8
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 436 8
 
 
C07D HETEROCYCLIC COMPOUNDS 258 25
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 228 6
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 197 54
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 133 15
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 122 34
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 35 16
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 30 63
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0029,984 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING Oct 03, 17 Feb 01, 18 [C07F, C07D]
2018/0021,431 METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS Jun 28, 17 Jan 25, 18 [A61K, C07K]
2018/0021,450 ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF Jun 02, 17 Jan 25, 18 [A61K]
2018/0022,707 THERAPEUTIC COMPOUNDS AND USES THEREOF Jul 07, 17 Jan 25, 18 [C07D]
2018/0022,727 THERAPEUTIC COMPOUNDS AND USES THEREOF Jul 07, 17 Jan 25, 18 [C07D]
2018/0022,813 ANTIGEN BINDING COMPLEX HAVING AGONISTIC ACTIVITY AND METHODS OF USE Oct 04, 17 Jan 25, 18 [A61K, C07K]
2018/0015,177 ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE Jun 27, 17 Jan 18, 18 [A61K, C07K]
2018/0015,179 ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES Jun 26, 17 Jan 18, 18 [A61K]
2018/0016,325 ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES Sep 28, 17 Jan 18, 18 [A61K, C07K]
2018/0009,735 THERAPEUTIC COMPOUNDS AND USES THEREOF Jul 24, 17 Jan 11, 18 [C07D, C07C, A61K]
2018/0009,805 THERAPEUTIC COMPOUNDS AND USES THEREOF Jul 24, 17 Jan 11, 18 [C07D, A61K]
2018/0009,894 ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES Jul 24, 17 Jan 11, 18 [G01N, A61K, C07K]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9879066 Influenza A H7N9 virus therapies Jul 21, 16 Jan 30, 18 [A61K, C07K]
9879094 Nucleic acid molecules encoding for BACE1 antibodies Aug 11, 16 Jan 30, 18 [C07H, C12P, G01N, A61K, C07K]
9879267 Genetic variations associated with drug resistance Mar 12, 09 Jan 30, 18 [C12N, C12Q, A61K]
9873684 Estrogen receptor modulators and uses thereof Dec 09, 15 Jan 23, 18 [C07D, A61K]
9873734 Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases Nov 05, 12 Jan 23, 18 [A61K, C07K]
9873740 Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors Jul 16, 14 Jan 23, 18 [A01K, A61K, C07K]
9873742 Methods for diagnosing and treating inflammatory bowel disease Mar 31, 15 Jan 23, 18 [C12P, C12Q, G01N, C07K]
9873748 Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 Dec 23, 14 Jan 23, 18 [A61K, C07K]
9867833 Serine/threonine kinase inhibitors Dec 03, 14 Jan 16, 18 [C07D, A61K]
9868704 Estrogen receptor modulators and uses thereof Jun 17, 16 Jan 16, 18 [C07D, C07C, A61K]
9868720 C-linked heterocycloaklyl substituted pyrimidines and their uses Oct 30, 15 Jan 16, 18 [C07D, A61K]
9868760 Protein purification Mar 18, 14 Jan 16, 18 [B01D, C07K]
9862689 Processes for the preparation of pyrimidinylcyclopentane compounds Nov 13, 14 Jan 09, 18 [C07D, C12P, C07C]
9862778 Assembly of bispecific antibodies Apr 11, 14 Jan 09, 18 [C07K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0233,486 POLYNUCLEOTIDES ENCODING ANTI-NOTCH1 NRR ANTIBODY POLYPEPTIDES ABAN Nov 22, 16 Aug 17, 17 [C07K]
2017/0210,733 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE ABAN Apr 07, 17 Jul 27, 17 [C07D]
2017/0210,807 HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR ABAN Apr 11, 17 Jul 27, 17 [C07K]
2017/0145,020 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF ABAN Feb 03, 17 May 25, 17 [C07D]
2017/0145,034 ALKYNYL ALCOHOLS AND METHODS OF USE ABAN Feb 06, 17 May 25, 17 [C07D]
2017/0106,042 METHODS AND COMPOSITIONS FOR MODULATING HGF/MET ABAN May 23, 16 Apr 20, 17 [G01N, A61K, C07K]
2017/0044,261 HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR ABAN Mar 24, 16 Feb 16, 17 [C07K]
2017/0001,990 PIPERIDINE-DIONE DERIVATIVES ABAN Sep 15, 16 Jan 05, 17 [C07D]
2017/0002,017 N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF ABAN Feb 05, 16 Jan 05, 17 [C07D, C07C]
2017/0000,885 METHODS OF TREATING CANCER USING ANTI-OX40 ANTIBODIES AND PD-1 AXIS BINDING ANTAGONISTS ABAN Jun 07, 16 Jan 05, 17 [A61K]
2016/0333,011 TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS ABAN Jul 26, 16 Nov 17, 16 [C07D]
2016/0326,142 PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ABAN May 11, 16 Nov 10, 16 [C07D]
2016/0311,817 HETEROARYL SULTAM DERIVATIVES AS RORc MODULATORS ABAN Jul 06, 16 Oct 27, 16 [C07D]
2016/0304,613 NEUROPILIN ANTAGONISTS ABAN Feb 06, 15 Oct 20, 16 [A61K, C07K]
2016/0296,634 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR ABAN Nov 19, 15 Oct 13, 16 [A61K, C07K]
2016/0279,241 ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER ABAN Jun 16, 16 Sep 29, 16 [A61K]
2016/0279,190 MODULATION OF AXON DEGENERATION ABAN Jun 30, 15 Sep 29, 16 [C12N, A61K, C07K]
2016/0272,699 HUMANIZED ANTIBODY ABAN Oct 28, 15 Sep 22, 16 [G01N, C07K]
2016/0244,456 PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS ABAN May 02, 16 Aug 25, 16 [C07D]
2016/0244,514 Humanized Antibody ABAN Dec 22, 15 Aug 25, 16 [A61K, C07K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

Owner Watch
Genentech, Inc.
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL